Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study)

INTRODUCTION: Scabies is a significant contributor to global morbidity, affecting approximately 200 million people at any time. Scabies is endemic in many resource-limited tropical settings. Bacterial skin infection (impetigo) frequently complicates scabies infestation in these settings. Community-w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open
Autors principals: Lake, Susanna J, Phelan, Sophie L, Engelman, Daniel, Sokana, Oliver, Nasi, Titus, Boara, Dickson, Gorae, Christina, Schuster, Tibor, Grobler, Anneke C, Osti, Millicent H, Andrews, Ross, Marks, Michael, Whitfeld, Margot J, Romani, Lucia, Kaldor, John, Steer, Andrew
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Global Health
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7462236/
https://ncbi.nlm.nih.gov/pubmed/32868360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-037305
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars